Clinical Trials on Carbohydrate Metabolism Disorder
Total 160393 results
-
Genzyme, a Sanofi CompanyActive, not recruitingGlycogen Storage Disease Type IIFrance
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type IIChina
-
Duke UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedGlycogen Storage Disease Type IIUnited States
-
Columbia UniversityWithdrawnGlycogen Storage Disease Type IIUnited States
-
University of Texas Southwestern Medical CenterRecruitingGlucose Metabolism Disorders | Epilepsy | Glucose Transporter Type 1 Deficiency Syndrome | Glut1 Deficiency Syndrome 1 | Glut1 Deficiency Syndrome 1, Autosomal Recessive | Glucose Transporter Protein Type 1 Deficiency Syndrome | Glucose Transport DefectUnited States
-
University of California, San FranciscoRecruiting
-
Ultragenyx Pharmaceutical IncAvailableGlucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
-
Ultragenyx Pharmaceutical IncCompleted
-
Joyce FoxUltragenyx Pharmaceutical IncNo longer availableMucopolysaccharidosis Type 7United States
-
BioMarin PharmaceuticalCompletedMPS VIUnited States, Australia, France, Brazil, Germany, Portugal, United Kingdom
-
National Taiwan Sport UniversityCompletedCaffeine | CarbohydrateTaiwan
-
Lysosomal and Rare Disorders Research and Treatment...Team SanfilippoRecruitingSanfilippo Syndrome | MPS3United States
-
University of ThessalyNot yet recruiting
-
Allievex CorporationEnrolling by invitationMPS III BUnited States, Germany, Turkey, United Kingdom, Colombia
-
ArmaGen, IncCompletedMucopolysaccharidosis IBrazil
-
PATHFundação de Medicina Tropical Dr. Heitor Vieira DouradoCompleted
-
IRCCS San RaffaeleFondazione TelethonActive, not recruiting
-
Columbia UniversityNew York Blood CenterCompleted
-
University of ThessalyCompleted
-
Agios Pharmaceuticals, Inc.RecruitingPyruvate Kinase DeficiencyUnited States, Germany, Spain, Italy, United Kingdom, Czechia, France, Canada, Korea, Republic of, Netherlands, Turkey, Portugal, Denmark, Ireland, Switzerland, Thailand
-
Agios Pharmaceuticals, Inc.Active, not recruitingPyruvate Kinase DeficiencyUnited States, Canada, Netherlands, United Kingdom, France, Italy
-
Rocket Pharmaceuticals Inc.Active, not recruiting
-
Agios Pharmaceuticals, Inc.CompletedAnemia, Hemolytic | Pyruvate Kinase DeficiencyUnited States, United Kingdom, Netherlands, Canada, Denmark, France, Italy, Ireland, Thailand
-
SanofiRecruitingGlycogen Storage Disease Type IIBelgium, United States, China, Germany, Italy, Netherlands, Spain, Taiwan, United Kingdom
-
Taipei Veterans General Hospital, TaiwanUnknownGlycogen Storage Disease Type IITaiwan
-
Agios Pharmaceuticals, Inc.CompletedPyruvate Kinase DeficiencyUnited States, Italy, Netherlands
-
CENTOGENE GmbH RostockCompletedPyruvate Kinase DeficiencyUnited States
-
Agios Pharmaceuticals, Inc.CompletedAnemia, Hemolytic | Pyruvate Kinase DeficiencyUnited States, Spain, Switzerland, Turkey, Germany, France, United Kingdom, Japan, Netherlands, Brazil, Canada, Czechia, Denmark, Italy, Korea, Republic of, Thailand
-
Organon and CoCompleted
-
Taipei Veterans General Hospital, TaiwanNot yet recruitingGlycogen Storage Disease Type II
-
Genzyme, a Sanofi CompanyRecruitingMucopolysaccharidosis I (MPS I)Croatia, United States, Argentina, Australia, Belgium, Brazil, Canada, Denmark, France, Hong Kong, India, Indonesia, Korea, Republic of, Kuwait, Lebanon, Malaysia, Netherlands, Pakistan, Philippines, Poland, Saudi Arabia, Singapore, Slovaki... and more
-
Ultragenyx Pharmaceutical IncAvailableSly Syndrome | Mucopolysaccharidosis VII | MPS VII
-
LYSOGENEActive, not recruitingMucopolysaccharidosis Type IIIAGermany, United States, United Kingdom, France, Netherlands
-
ShireTerminatedSanfilippo Syndrome | Mucopolysaccharidosis (MPS)United States, United Kingdom, Spain, Germany, France, Italy, Netherlands
-
University of Mississippi, OxfordUniversity of Colorado, Denver; Southern Research InstituteUnknown
-
Alexion PharmaceuticalsCompletedMucopolysaccharidosis IIIBUnited States, United Kingdom, Spain
-
USDA Grand Forks Human Nutrition Research CenterCompleted
-
Université de MontréalFédération des producteurs acéricoles du QuébecCompletedAthletic Performance | Carbohydrate Ingestion | Fuel SelectionCanada
-
Glycemic Index Laboratories, IncAgriculture and Agri-Food CanadaCompletedCarbohydrate Intolerance
-
Mayo ClinicNational Institutes of Health (NIH); Oxalosis and Hyperoxaluria Foundation...WithdrawnKidney Stones | Nephrocalcinosis | Primary HyperoxaluriaUnited States
-
Luye Pharma Group Ltd.CompletedLipid Metabolism DisorderUnited States
-
Hasselt UniversityRecruitingExercise | Sedentary Behavior | Lipid Metabolism DisorderBelgium
-
Lo.Li.Pharma s.r.lCompleted
-
Institut de Myologie, FranceRecruitingMuscular Dystrophies | Mitochondrial Myopathies | Glycogen Storage Disease | Idiopathic Inflammatory Myopathies | Congenital MyopathyFrance
-
Institut de Myologie, FranceRecruitingMuscular Dystrophies | Mitochondrial Myopathies | Glycogen Storage Disease | Idiopathic Inflammatory Myopathies | Congenital MyopathyFrance
-
Massachusetts General HospitalRecruiting
-
CENTOGENE GmbH RostockWithdrawnSkeletal Abnormalities | Psychomotor RetardationGermany, India, Sri Lanka, Egypt
-
Immusoft of CA, Inc.RecruitingMucopolysaccharidosis IH/S | Mucopolysaccharidosis ISUnited States
-
Ultragenyx Pharmaceutical IncActive, not recruitingGlycogen Storage Disease Type IAUnited States, Brazil, Canada, Denmark, Germany, Italy, Netherlands, Spain
-
University of ManchesterUniversity College, London; Manchester University NHS Foundation Trust; Orchard... and other collaboratorsActive, not recruitingMucopolysaccharidosis Type IIIAUnited Kingdom